Reduced haloperidol

(±)-4-(4-Chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol

1-Piperidinebutanol, 4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-

34104-67-1

4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-hydroxybutyl)-4-piperidinol

4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]-4-piperidinol

4-(4-Chlorophényl)-1-[4-(4-fluorophényl)-4-hydroxybutyl]-4-pipéridinol

4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol

4-(4-Chlorphenyl)-1-[4-(4-fluorphenyl)-4-hydroxybutyl]-4-piperidinol

Haloperidol metabolite II

MFCD00055102

Reduced haloperidol

1-Piperidinebutanol, 4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-(R/S)

1-PIPERIDINEBUTANOL,4-(4-CHLOROPHENYL)-A-(4-FLUOROPHENYL)-4-HYDROXY-(R/S)

1246820-79-0

136271-60-8

136271-61-9

35285-54-2

4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol

4-(4-Chloro-phenyl)-1-[4-(4-fluoro-phenyl)-4-hydroxy-butyl]-piperidin-4-ol

4-(4-Chlorophenyl)-a-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol

4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol

D(2) dopamine receptor

D(3) dopamine receptor

Dihydrohaloperidol

DRD2_HUMAN

DRD2_RAT

DRD3_RAT

Hydroxy-haloperidol

Hydroxyhaloperidol

REDUCED HALOPERIDOL-D4

SGMR1_CAVPO

SGMR2_RAT

Sigma intracellular receptor 2